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Anxiety is highly prevalent in children with an autism spectrum disorder (ASD). However, 
there is inconsistency in studies investigating the prevalence and risk factors of anxiety 
in children with ASD. Therefore, the first aim of this study was to give an overview of 
the prevalence of anxiety symptoms in a clinical Dutch sample of children with ASD. 
The second aim was to investigate age, gender, ASD subtype, and IQ as potential risk 
factors for anxiety in this sample. In total, 172 children with ASD (age, 8–15 years) and 
their parents participated in this study. Specialized services in which children with ASD 
were recruited were two mental health institutes and one secondary special education 
school. The findings showed that more than 60% of the participating children with ASD 
had at least subclinical anxiety symptoms according to children. More than 80% of 
the children with ASD had at least subclinical anxiety symptoms according to parents. 
It was found that younger children and girls with ASD had more anxiety symptoms than 
older children and boys with ASD. Moreover, it was found that children with a higher 
performance (non-verbal) IQ and lower verbal IQ had more specific phobia symptoms. 
The findings suggest that in a clinical context, children with ASD have a high risk to 
have co-occurring anxiety symptoms, especially girls and younger children with ASD. 
Therefore, early prevention and treatment of anxiety in children with ASD who are most 
at risk is important.
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inTrODUcTiOn
Recent studies have demonstrated that comorbid psychiatric problems are common among chil­
dren with an autism spectrum disorder [ASD; e.g., Ref. (1)]. Anxiety is one of the most prevalent 
comorbid psychiatric problems in children with ASD, with prevalence rates varying between 11 
and 84% (2). More specifically, it has been shown that 56% of the children with an ASD suffer 
from at least subclinical anxiety (3), and approximately 40% of the children with an ASD meet the 
criteria of at least one anxiety disorder (4). Some of the most frequently reported anxiety disorders 
and symptoms seen in children with an ASD are specific phobias, generalized anxiety disorder, 
separation anxiety disorder, obsessive–compulsive disorder, and social phobia (2).
The distinct anxiety disorders show a wide variation in prevalence rates [11–84% (2)] in the 
population of children with ASD. The big differences in prevalence rates are mainly due to sample 
and methodological heterogeneity, differences in the assessment of anxiety in children with ASD, 
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and differences in the operationalization of anxiety (5). In some 
studies, only parent report of anxiety was used [e.g., Ref. (6)], 
whereas in other studies, a combination of parent and child 
[e.g., Ref. (7)] or parent and teacher (8) report of anxiety was 
used. These respondents differ in their assessment of anxiety 
in children with ASD. For example, there is some evidence 
that teachers give higher ratings of anxiety than parents (9). 
Moreover, some children with ASD may have difficulties with 
emotional insight or accurately detecting and interpreting 
one’s own emotions (2), which could lead to higher symptom 
ratings of parents compared to children. However, other 
children with ASD might be able to report on their own stress 
and social attributions (10). For example, ASD children with 
age appropriate intellectual and verbal abilities have relatively 
intact emotion recognition abilities (11). This implicates that 
some children with ASD may at least be comparable to parents 
in their report of anxiety symptom levels. Furthermore, anxiety 
could be conceptualized as anxiety symptoms measured by a 
questionnaire (7), but also as anxiety disorders measured by a 
structured interview (12). The use of interviews is associated 
with higher prevalence rates of total anxiety, while for social 
anxiety disorder, the use of questionnaires is associated with 
higher prevalence rates (4). These conceptual and methodologi­
cal differences and the heterogeneity of the ASD population may 
lead to variation in the prevalence rates across studies.
Because anxiety causes significant impairment in children 
with ASD, it is important that efforts are made to improve the 
identification and assessment of these symptoms. The impair­
ments caused by anxiety consist of poor daily living skills and 
problems in relationships with peers, teachers, and family 
(13–15). Moreover, anxiety underlies comorbid symptoms of 
children with an ASD, for example, oppositional and aggressive 
behavior (16) and depressive symptoms (17). The impairments 
and comorbid symptoms caused by anxiety also underline the 
importance of effective treatment of anxiety and prevention of 
further escalation.
To be able to prevent further escalation of anxiety, it is impor­
tant that risk factors that predict the development of anxiety 
are identified. In this way, children with ASD can be profiled 
on vulnerability for the development of anxiety. Moreover, 
prevention and treatment can specifically be tailored to the ASD 
children with elevated risk to develop anxiety. In the literature, 
several potential but inconsistent risk factors for the develop­
ment of anxiety in children with ASD are identified. Again, 
the inconsistency in risk factors is often due to conceptual and 
methodological differences between studies and the heterogene­
ity of the ASD population (5).
Age is one of the potential but inconsistent risk factors. Most 
studies reported that anxiety in children with ASD increases 
from preschool to adolescence [e.g., Ref. (18, 19)]. Potentially, 
the delayed cognitive and motor developments in children with 
ASD do not permit the recognition and expression of anxiety 
symptoms until adolescence (18). However, there is also evidence 
that only clinical anxiety is higher in adolescents with ASD com­
pared to school children with ASD and that subclinical anxiety 
is higher in school children with ASD compared to adolescents 
with ASD (17).
There are also mixed data regarding the differential preva­
lence rates of anxiety for girls and boys with ASD. Some studies 
showed that girls with ASD have more anxiety symptoms (9), 
and other studies showed that anxiety is more prevalent in boys 
with ASD (20). There are more studies showing that anxiety 
symptoms are equally prevalent in boys and girls with ASD 
(17, 21, 22). This could be explained by the hypothesis that the 
shared neurobiological dysfunctions in boys and girls with ASD 
have an overriding effect on psychopathology, leading to com­
parable anxiety levels in boys and girls with ASD (23).
Moreover, several studies showed that the prevalence of 
anxiety varies among the different subtypes of ASD. The stud­
ies that specifically focused on comparing anxiety levels across 
ASD subtypes suggest that ASD severity is associated with the 
level of anxiety and that children with less severe ASD symptoms 
might be most comorbid with anxiety (24). Specifically, children 
with Asperger disorder experience more anxiety than children 
with PDD­NOS, and children with PDD­NOS experience more 
anxiety than children with autistic disorder (2, 9, 25). This is in 
line with research that showed that higher IQ or better cognitive 
functioning predicted more severe anxiety in children with ASD 
[e.g., Ref. (1, 17, 20)], because children with Asperger disorder 
have a higher IQ than children with PDD­NOS and autistic 
disorder [e.g., Ref. (26)]. Higher IQ and developmental level may 
allow children with Asperger disorder to engage more in higher 
order cognitions (e.g., worry, foresight, and imagery), which 
are the hallmark of several anxiety disorders (5). Moreover, it is 
possible that children with a higher IQ are more exposed to situ­
ations (e.g., interactions with peers) that provoke social anxiety 
(1). Finally, children with Asperger disorder have better verbal 
capacities than children with PDD­NOS and autistic disorder, 
which supports the communication of anxiety to parents and 
teachers (1).
Conversely, there is some evidence that anxiety in general is 
more common in children with PDD­NOS, followed by children 
with autistic disorder and Asperger disorder (4). Moreover, 
Dickerson Mayes et  al. (19) found that anxiety increased with 
autism severity. In line with this, some studies reported that a 
lower mean IQ of children with ASD is associated with higher 
prevalence rates of anxiety [e.g., Ref. (4)]. Because children with 
PDD­NOS and autistic disorder have more severe ASD symp­
toms than children with Asperger disorder, they may experience 
more ASD­related anxiety, for example, anxiety for unexpected 
social situations (4).
Furthermore, the verbal IQ (VIQ) and performance (non­
verbal) IQ (PIQ) should be considered as more specific risk 
factors for anxiety in children with ASD. PIQ is often relatively 
high and VIQ relatively low in children with ASD (27). This 
is consistent with the core ASD symptom of communication 
impairments, which may be reflected in weak verbal capaci­
ties in children with ASD. Unlike in the normal population, 
impairments in communication may have an inverse relation­
ship with anxiety in children with ASD. For example, deficits 
in both receptive and expressive communication skills are 
associated with less anxiety symptoms in children with ASD 
(28). In line with this finding, there is some evidence that ASD 
children with lower non­verbal and higher verbal skills show 
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more anxiety and mood problems, which would mean that a 
low PIQ and high VIQ are related to more anxiety in children 
with ASD (15). However, other research showed that children 
with PDD­NOS had higher anxiety levels as communication 
deficits increased (29).
It can be concluded that there is inconsistency in results of 
studies investigating prevalence and risk factors of anxiety in 
children with ASD. Therefore, the first aim of this study was 
to give an overview of the prevalence of anxiety symptoms in 
a clinical Dutch sample of children with ASD. The second aim 
was to investigate the risk factors for anxiety in this sample of 
children with ASD. More specifically, age, gender, ASD subtype, 
and IQ were examined as potential risk factors for anxiety in 
children with ASD. We expected that older children with ASD 
experience more anxiety than younger children with ASD and 
that there was no difference in anxiety between boys and girls 
with ASD. Also, we expected that children with Asperger disor­
der experience more anxiety than children with PDD­NOS and 
autistic disorder. In line with this, we expected that ASD children 
with a higher (V)IQ experience more anxiety than children with 
a lower (V)IQ.
It is believed that this study provides new knowledge on the 
field of anxiety in children with ASD, because both parent­ and 
child­rated anxiety levels were measured and these levels were 
compared. In the majority of the previous studies on anxiety 
in children with ASD [e.g., Ref. (3, 17, 30)], only parent­rated 
anxiety levels were measured. Since children with ASD have 
shown to be able to accurately report their anxious cognitions 
(31), self­reports of anxiety can add important valuable new 
knowledge about the way in which children with ASD assess 
their own internalizing symptoms. Moreover, there are hardly 
any studies that examined anxiety levels in children with ASD 
in Dutch children with ASD [e.g., Ref. (32)], and most studies 
included large community samples of children with ASD with all 
levels of impairment [e.g., Ref. (30)], while in this study, a specific 
clinical sample children with ASD was included who had a high 
level of daily impairment and who received intensive treatment 
at a mental health institute.
MaTerials anD MeThODs
Procedures
In this study, screening data on anxiety were obtained that 
was later used for the inclusion of participants in a rand­
omized controlled trial (RCT) testing the effect of an anxiety 
intervention for children with an ASD [see study protocol in 
Ref. (33)]. This RCT (including the screening procedure) was 
carried out with approval of the medical ethics committee 
“Commissie Mensgebonden Onderzoek Arnhem­Nijmegen” in 
the Netherlands (NL50023.091.14) and in accordance with the 
ethical standards of the Declaration of Helsinki as revised in 
2000. Passive consent was received to use the screening data of 
children and parents in this study. However, when they eventu­
ally participated in the RCT and they received an intervention 
(experimental or control condition), active and written informed 
consent was received.
Specialized services in which children with ASD were 
recruited were two mental health institutes and one secondary 
special education school. First, parents received a letter with 
information about the study. If parents and children were inter­
ested in participation after reading the letter, they both filled in 
screening questionnaires on anxiety [Spence Children’s Anxiety 
Scale for Children (SCAS­C) (34) and Spence Children’s Anxiety 
Scale for Parents (SCAS­P) (35)]. All children and parents (with 
passive consent) who filled in screening questionnaires were 
part of this study, regardless of their anxiety levels and eventual 
participation in the RCT.
Participants
In total, 172 children with an ASD (autistic disorder, Asperger 
disorder, and PDD­NOS) and their parents participated in this 
study. Of the participating children, 134 were males (77.9%) 
and 38 were females (22.1%). Their age was between 8 and 
15  years (M =  11.25, SD =  2.02). Furthermore, 105 children 
were in primary school (61.0%) and 67 were in secondary 
school (39.0%). Of the children in primary school, 39 followed 
special education (37.1%). Of the children in secondary school, 
38 followed special education (56.7%). Moreover, 29 children 
in secondary school followed vocational training (43.3%), 2 
followed vocational training/high school training (3.0%), 8 
followed high school training (11.9%), 15 followed high school 
training/pre­university training (22.4%), 6 followed pre­ 
university training (9.0%), and 5 (7.5%) followed other sec­
ondary education. Most of the children were of Dutch origin 
(>90%). Inclusion criterion was sufficient knowledge of the 
Dutch language. Exclusion criteria were absence of parental 
permission and presence of prominent suicidal ideation or 
other severe psychiatric problems that needed immediate treat­
ment (e.g., severe trauma).
instruments
Anxiety Symptoms
A Dutch translation of the SCAS­C (34) was used to measure 
anxiety symptoms of the participating children. The SCAS 
consists of 44 items on a 4­point scale, ranging from “never” to 
“always.” Scores on items range from 0 to 3, with higher scores 
indicating more anxiety symptoms. Moreover, the scale consists 
of six subscales that are in line with the different anxiety disor­
ders that are described in the Diagnostic and Statistical Manual 
of Mental Disorders, fourth edition—Text Revision [DSM­
IV­TR (36)]. However, the obsessive–compulsive subscale was 
not included in this study, because in children with ASD, this 
behavior is often not related to anxiety, but serves as a form of 
self­soothing behavior or as a regulation of excitement or arousal 
(37). Moreover, in the DSM­V (38), the obsessive–compulsive 
disorder was not defined as an anxiety disorder anymore (39). 
Furthermore, the fear of physical injury subscale was defined as 
“specific phobia” in this study. This is because the items of the 
SCAS­C/P that belong to this subscale do not only refer to fear 
of physical injury but also refer to other specific fears like fear of 
heights and fear of darkness. The SCAS­C contains six positive 
filler items, which are not used in the calculation of the total 
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score or subscale scores. The SCAS has a high validity and reli­
ability (32, 40). Moreover, anxiety symptoms that are measured 
with both the SCAS­C can be reliably clustered into the anxiety 
disorder categories as described in the DSM­IV (41). Cronbach’s 
alpha was 0.94.
Moreover, a Dutch translation of the SCAS­P (35) was used 
to measure anxiety symptoms of the participating children 
according to the parents. The SCAS­P consists of 38 items on a 
4­point scale ranging from 0 (never) to 3 (always). The items of 
the SCAS­P were formulated as closely as possible to the cor­
responding item of the child version of the SCAS. The SCAS­P 
consists of the same six subscales as the child version. Also for 
the SCAS­P, the obsessive compulsive subscale was not included, 
and the fear of physical injury subscale was defined as “specific 
phobia” in this study. The SCAS­P has a good reliability and 
validity (42). Moreover, anxiety symptoms that are measured 
with both the SCAS­P can be reliably clustered into the anxiety 
disorder categories as described in the DSM­IV (42). Cronbach’s 
alpha was 0.90.
ASD and Comorbid Diagnoses
All the participating children were diagnosed with an ASD at 
a mental health institute in the Netherlands. Of these children, 
119 were diagnosed with the ASD subtype PDD­NOS (69.2%), 
29 were diagnosed with the ASD subtype Asperger disorder 
(16.9%), and 22 were diagnosed with the ASD subtype autistic 
disorder (12.8%). ASD diagnoses were based on the psycho­
logical and/or psychiatric assessment of the DSM­IV criteria for 
autistic disorder, Asperger’s disorder, or PDD­NOS. This assess­
ment was adapted to the diagnostic “needs” of the individual 
child and for example consisted of a developmental anamnesis 
with parents, contact with the child’s teacher, and/or stand­
ardized observation of the child with the Autism Diagnostic 
Observation Scale (43). Comorbid diagnoses were attention 
deficit hyperactivity disorder (45.3%), (persistent) depressive 
disorder (7.0%), oppositional defiant disorder (3.5%), obses­
sive–compulsive disorder (1.7%), reactive attachment disorder 
(1.7%), and posttraumatic stress disorder (1.2%). Moreover, 
9.3% of the participating children had some kind of learning 
disability (e.g., dyslexia).
IQ
The level of cognitive functioning (IQ) was measured by an 
intelligence test. Of the participating children, 141 children 
underwent an intelligence test in their clinical trajectory at the 
mental health institute where they were treated. The total IQ 
(TIQ) is an indicator of the overall level of cognitive function­
ing and consists of a VIQ and a PIQ. Only VIQ and PIQ were 
included as variables in this study. This because in this study, 
the mean absolute difference between VIQ and PIQ was 12.85 
(SD = 9.04). A discrepancy of this magnitude is often considered 
to be statistically significant (44), with the consequence that TIQ 
was not a reliable indicator of the level of cognitive functioning 
of the participating children. Therefore, VIQ and PIQ could be 
better used as separate indicators of the level of verbal and non­
verbal cognitive functioning. If children had a history of multiple 
IQ assessments, the most recent IQ measurement was included. 
In this study, the mean VIQ was M = 104.87, and the mean PIQ 
was M = 97.85.
In total, 134 children were assessed by the third edition of the 
Wechsler Intelligence Scale for Children (44), which has shown to 
be a reliable and valid intelligence test for children of 6–16 years 
old. Because two children were under the age of 6 years when 
they had their most recent IQ assessment, they underwent an 
alternative intelligence test. One child was assessed by the Revisie 
Amsterdamse Kinderintelligentie Test (45), and the other child 
was assessed by the third edition of the Wechsler Preschool and 
Primary Scale of Intelligence (46). Finally, five children were 
assessed by the non­verbal intelligence test Snijders­Oomen 
Niet­verbale Intelligentietest 2,5­7 (47).
analysis
First, the prevalence of anxiety symptoms in the participating 
children with ASD was assessed. Descriptive statistics (means 
and SDs) were retrieved from child­ and parent­rated SCAS 
total anxiety and SCAS subscales of generalized anxiety, specific 
phobia, social phobia, separation anxiety, and panic disorder/
agoraphobia. To assess the prevalence of elevated anxiety 
symptoms, the cutoffs for subclinical anxiety scores were used. 
By using the Dutch norm data of the SCAS­C (41) and the Dutch­
Australian norm data of the SCAS­P (42), a subclinical score on 
total anxiety and all subscales was defined by a score of >M ± 1 
SD on the SCAS­C/P. The norms for the SCAS­P were based on 
the means and SDs for the “normal control children” (separately 
for boys and girls) in the age of 6–11 years (for the children of 
8–11  years) and 12–18  years (for the children of 12–15  years) 
that were reported in the study by Nauta et al. (42). The norms 
for the SCAS­C were based on the means and SDs for boys and 
girls in the age of 7–12 years (for the children of 8–12 years) and 
13–19 years (for the children of 13–15 years) that were reported 
in the study by Muris et al. (41).
Second, two series of path analyses were performed using 
Mplus version 7.2 (48) to examine the relationship between 
potential risk factors and anxiety symptoms of the participating 
children as reported by the children (series 1) and as reported 
by their parents (series 2). For both series, path analyses were 
applied with risk factors (gender, age, VIQ, performance IQ, and 
ASD subtypes) as predictors and anxiety symptoms as depend­
ent variables. By using this type of analysis, predictors were free 
to correlate. The advantage of path analysis above regression 
analysis was that all available information of the data was used. 
To estimate the parameters of the path model, the Bayes estimator 
was applied based on the Markov Chain Monte Carlo estimation 
using diffuse (non­informative) prior probability distributions 
as default. The Bayesian estimation was used, because the more 
traditional estimation method (Maximum Likelihood) failed 
due to model identification issues (49). The fit of the model was 
evaluated by posterior predictive checking expressed in posterior 
predictive p values (PPP). PPP values of 0.50 implied good model 
fit, and small PPP values (e.g., <0.05) implied poor model fit 
(49, 50). Standardized posterior regression coefficients were 
reported with Bayesian p values if p < 0.05.
The composition of ASD subtypes consisted of three catego­
ries: PDD­NOS, Asperger disorder, and autistic disorder. Effects 
Table 2 | Counts, Percentages, and χ2(1) Values of Children with at Least 
Subclinical Anxiety Symptoms According to Parent and Child Assessment.
children  
(n = 168), n (%)
Parents  
(n = 168), n (%)
χ2 (1)  
value
Total anxiety 67 (39.9) 104 (61.9) 22.74***
Separation anxiety 60 (35.7) 80 (47.6) 7.52**
Social phobia 79 (47.0) 78 (46.4) 0.00
Panic disorder/agoraphobia 55 (32.7) 94 (56.0) 22.22***
Specific phobia 62 (36.9) 71 (42.3) 1.42
Generalized anxiety 54 (32.1) 82 (48.8) 13.50***
n, number.
**p ≤ 0.01.
***p ≤ 0.001.
Table 1 | Means and SDs of the Total and Subscale Scores of Children 
(SCAS-C) and Parents (SCAS-P).
children  
(n = 168), M (sD)
Parents  
(n = 172), M  (sD)
Total anxiety 29.03 (18.47) 29.07 (14.61)
Separation anxiety 4.37 (3.90) 5.18 (3.62)
Social phobia 5.76 (3.92) 6.79 (3.74)
Panic disorder/agoraphobia 4.37 (4.55) 4.05 (3.42)
Specific phobia 4.20 (2.88) 4.63 (2.94)
Generalized anxiety 5.39 (3.65) 4.65 (2.61)
n, number; M, means.
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of the three groups on anxiety symptoms and disorders were 
examined using unweighted effects coding (51). Two codes 
represented the three groups PDD­NOS, Asperger disorder, 
and autistic disorder; one coded 1, 0, and −1 and the second 
0, 1, and −1, respectively. Regression weights represented the 
deviation of the outcome variable for each separate group from 
the grand mean. Only the effects of PDD­NOS and Asperger 
disorder were visible in the output. To determine the effect of 
autistic disorder on anxiety symptoms and disorders, a second 
path analysis was conducted with a different coding system 
(−1, 1, 0 and −1, 0, 1) (51).
effects of Missing Data
Because 31 children did not undergo an intelligence test (18.0% of 
172), logistic regression analyses were conducted in SPSS 21 (52) 
to examine the attrition effects for sex and age. For the analyses 
on the effect of risk factors on anxiety symptoms (SCAS­C/P), 
attrition on VIQ and PIQ was the dependent binary variable. No 
differences in attrition were found for both sex (OR, 0.78; 95% 
CI, 0.29–2.06, p = 0.61) and age (OR, 1.10; 95% CI, 0.91–1.33; 
p = 0.33).
resUlTs
Prevalence of anxiety symptoms
Table  1 shows the means and SDs of the total and subscale 
SCAS scores of the parents (SCAS­P) and children (SCAS­C). 
Table  2 shows the counts and percentages of children with at 
least subclinical anxiety symptoms according to parent and child 
assessment. In total, 66.3% of the participating children with 
ASD had child­rated subclinical or clinical anxiety symptoms on 
the total scale and/or on at least one subscale and 81.4% of the 
participating children with ASD had parent­rated subclinical or 
clinical anxiety symptoms on the total scale and/or on at least 
one subscale. It showed that for all anxiety disorders, more than 
30% of the participating children with ASD experienced at least 
subclinical anxiety symptoms according to assessments of both 
parents and children. The parent assessment showed that for total 
anxiety and panic disorder/agoraphobia, more than 50% of the 
participating children with ASD experienced at least subclinical 
anxiety symptoms.
To assess whether the difference in number of children with at 
least subclinical anxiety between the parent and child ratings was 
significant, the McNemar test for related proportions [χ2(1)] was 
conducted (see Table 2). The number of children with parent­
rated subclinical total anxiety (p <  0.001), separation anxiety 
(p = 0.006), panic disorder/agoraphobia (p < 0.001), and general­
ized anxiety (p < 0.001) was significantly higher than the number 
of children with child­rated subclinical anxiety on these anxiety 
scales. Parent and child ratings did not significantly differ in the 
number of children with subclinical social phobia and specific 
phobia (p > 0.05).
risk Factors for anxiety symptoms  
of children with asD
For child­rated anxiety symptoms and parent­rated child anxiety 
symptoms, path analyses were conducted using the Bayes estima­
tor. Each of the 18 path models show a fit with PPP values varying 
between 0.433 and 0.438, which implied a good fit (49).
age and gender
The path analyses results for child­rated anxiety symptoms are 
shown in Table 3. Girls with ASD had significantly more total 
anxiety symptoms than boys with ASD (β =  0.23, p <  0.01). 
Moreover, girls with ASD had significantly more separation 
anxiety symptoms (β = 0.13, p < 0.05), social phobia symptoms 
(β  =  0.23, p  <  0.01), panic disorder/agoraphobia symptoms 
(β = 0.30, p < 0.001), and generalized anxiety symptoms (β = 0.19, 
p < 0.01) than boys with ASD. Gender was not a significant pre­
dictor of specific phobia symptoms.
Concerning the predictor age, younger children with ASD had 
significantly more child­rated total anxiety symptoms than older 
children with ASD (β = −0.14, p < 0.05). Also, younger children 
with ASD had significantly more separation anxiety symptoms 
(β = −0.32, p < 0.001) than older children with ASD. Age was 
not a significant predictor of social phobia symptoms, specific 
phobia symptoms, panic disorder/agoraphobia symptoms, and 
generalized anxiety symptoms.
In Table  4, the path analyses results for parent­rated child 
anxiety symptoms are shown. Girls with ASD had significantly 
more total anxiety symptoms than boys with ASD (β =  0.17, 
p = 0.01). Moreover, girls with ASD had significantly more social 
phobia symptoms (β =  0.21, p <  0.01), panic disorder/agora­
phobia symptoms (β = 0.22, p < 0.01), and generalized anxiety 
symptoms (β = 0.22, p < 0.01) than boys with ASD. Gender was 
not a significant predictor of separation anxiety symptoms and 
specific phobia symptoms.
Table 4 | Path Analyses with Age, Gender, IQ (VIQ, PIQ), and ASD subtype (autistic disorder, Asperger disorder, and PDD-NOS) as Predictors and Parent-rated 
Symptoms of Total Anxiety, Separation Anxiety, Social Phobia, Panic Disorder/Agoraphobia, Specific Phobia, and Generalized Anxiety as Dependent Variables.
Total anxiety  
beta
separation anxiety 
beta
social phobia  
beta
specific phobia  
beta
Panic/agora phobia 
beta
generalized anxiety  
beta
Gender 0.17** 0.06 0.21** −0.01 0.22** 0.22**
Age −0.09 −0.27*** 0.10 −0.15* −0.03 −0.06
VIQ −0.02 0.01 0.05 −0.07 −0.08 −0.04
PIQ 0.14 0.12 0.07 0.14 0.15 0.14
PDD-NOS −0.09 −0.04 0.04 −0.11 −0.16* −0.06
AS −0.15 −0.05 −0.20** −0.10 −0.08 −0.09
AD 0.28** 0.10 0.22* 0.25* 0.27** 0.17
Betas are standardized regression weights.
AD, autistic disorder; AS, Asperger disorder; PIQ, performance (non-verbal) IQ; VIQ, verbal IQ.
*p ≤ 0.05.
**p ≤ 0.01.
***p ≤ 0.001.
Table 3 | Path Analyses with Age, Gender, IQ (VIQ, PIQ), and ASD subtype (autistic disorder, Asperger disorder, and PDD-NOS) as Predictors and Child-rated 
Symptoms of Total Anxiety, Separation Anxiety, Social Phobia, Panic Disorder/Agoraphobia, specific phobia, and Generalized Anxiety as Dependent Variables.
Total anxiety  
beta
separation anxiety  
beta
social phobia  
beta
specific phobia  
beta
Panic/agora 
phobia beta
generalized anxiety  
beta
Gender 0.23** 0.13* 0.23** 0.10 0.30*** 0.19**
Age −0.14* −0.32*** 0.06 −0.08 −0.10 −0.05
VIQ −0.07 −0.14 0.02 −0.22* 0.01 0.07
PIQ 0.07 0.08 0.01 0.20* −0.00 −0.02
PDD-NOS −0.01 −0.02 0.06 −0.10 0.05 0.04
AS 0.07 0.04 0.03 0.03 0.10 0.07
AD −0.08 −0.03 −0.10 0.06 −0.19 −0.13
Betas are standardized regression weights.
AD, autistic disorder; AS, Asperger disorder; PIQ, performance (non-verbal) IQ; VIQ, verbal IQ.
*p ≤ 0.05.
**p ≤ 0.01.
***p ≤ 0.001.
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Concerning the predictor age, younger children with ASD 
had significantly more parent­rated separation anxiety symp­
toms (β = −0.27, p <  0.001) and specific phobia symptoms 
(β = −0.15, p < 0.05) than older children with ASD. Age was not 
a significant predictor of total anxiety, social phobia symptoms, 
panic disorder/agoraphobia symptoms, and generalized anxiety 
symptoms.
iQ
Children with a lower VIQ had significantly more child­rated 
specific phobia symptoms than children with a higher VIQ 
(β = −0.22, p < 0.05), and children with a higher PIQ had sig­
nificantly more specific phobia symptoms than children with a 
lower PIQ (β = 0.20, p < 0.05; see Table 3). VIQ and PIQ were not 
found to be significant predictors of all other child­rated subscale 
anxiety symptoms. According to parents, VIQ and PIQ were not 
significant predictors of all parent­rated total and subscale anxi­
ety symptoms (see Table 4).
asD subtypes
For child­rated anxiety, none of the three ASD subtypes were 
significant predictors of all child­rated total and subscale anxi­
ety symptoms (see Table 3). For parent­rated anxiety, children 
with PDD­NOS had significantly less panic disorder/agorapho­
bia symptoms (β = −0.16, p <  0.05) compared to the overall 
mean of this variable (see Table  4). Moreover, children with 
Asperger disorder had significantly less social phobia symptoms 
(β = −0.20, p =  0.01) compared to the overall mean of this 
variable. Children with autistic disorder had significantly more 
total anxiety symptoms (β = 0.28, p < 0.01), more social phobia 
symptoms (β = 0.22, p < 0.05), more specific phobia symptoms 
(β  =  0.25, p  <  0.05), and more panic disorder/agoraphobia 
symptoms (β = 0.27, p = 0.01) compared to the overall means 
of these variables.
DiscUssiOn
The first aim of this study was to provide an overview of the 
prevalence of anxiety symptoms in a clinical Dutch sample of 
children with ASD. The findings showed that the prevalence 
of both parent­rated and child­rated subclinical and clinical 
anxiety symptoms was high: more than 60% of the participating 
children with ASD had at least subclinical anxiety symptoms 
according to children and more than 80% of the children had 
at least subclinical anxiety symptoms according to parents. 
Parents reported higher total anxiety, separation anxiety, panic 
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disorder/agoraphobia, and generalized anxiety than children. The 
results of this study provide new knowledge on the field of anxi­
ety in children with ASD, because child­rated anxiety levels were 
measured, and these levels were compared with parent­rated 
anxiety levels, while in the majority of the previous studies on 
anxiety in children with ASD [e.g., Ref. (3, 17, 30)], only parent­
rated anxiety levels were measured. Moreover, there are hardly any 
studies that examined anxiety levels in Dutch children with ASD 
[e.g., Ref. (32)], and most studies included large community 
samples of children with ASD with all levels of impairment [e.g., 
Ref. (30)], while in this study, a specific clinical sample children 
with ASD was included who had a high level of daily impairment 
and who received intensive treatment at a mental health institute.
The child­rated prevalence of anxiety (66.3%) that was found 
in this study was only slightly higher than the prevalence rates in 
the study of Strang et al. (3) and Vasa et al. (17). They found that 
56 (3), 52 (school children) (17), and 54% (adolescents) (17) of 
the children with ASD had at least subclinical anxiety symptoms. 
However, other studies found that only 22 (8) and 46% (30) of 
the children with ASD had at least subclinical anxiety symptoms. 
Moreover, the parent­rated prevalence (81.4%) of anxiety that 
was found in this study was higher than the prevalence rates that 
were found in all the above described studies (3, 8, 17, 30).
There are several possible explanations for the relatively high 
prevalence rates in this study. The prevalence rates of anxiety 
may differ as a result of the differences in levels of cognitive 
functioning between the participants included in the studies. 
The participating children in the study by Gotham et al. (30) had, 
for example, a mean VIQ of 80 and a mean non­VIQ of 86. The 
children who participated in this study had a relatively high mean 
VIQ and non­VIQ of, respectively, 105 and 98, and higher IQ has 
shown to be related to higher levels of anxiety [e.g., Ref. (1, 20)].
Moreover, it is possible that the differences in prevalence 
rates are due to the use of different cutoffs for anxiety symptoms. 
Strang et al. (3), for example, reported prevalence rates of sub­
clinical anxiety on the basis of a borderline score on a general 
anxiety scale of a questionnaire, while in this study, subclinical 
anxiety was defined as a subclinical score on the total scale and/
or on at least one subscale of the SCAS­C/P. When the prevalence 
rates of subclinical anxiety were only based on the total SCAS 
scale, 43.3% of the children had child­rated subclinical anxiety 
symptoms and 63.4% of the children had parent­rated subclini­
cal anxiety symptoms in this study. These percentages are more 
comparable to those that were found in other studies (3, 17, 30).
It is also possible that the difference in cultural background 
of the participants in this study, and previous studies could be 
an explanation for the differences in outcomes. Several studies 
showed that SCAS­based anxiety scores differ among different 
cultures and countries (53, 54). Since previous studies predomi­
nantly or entirely included American participants and mostly 
used American norm data [e.g., Ref. (30)] and this study included 
only Dutch participants and used Dutch norm data (SCAS­C) 
and Dutch–Australian norm data (SCAS­P), it is possible that the 
difference in origin and cultural background partly explained the 
difference in reported prevalence of anxiety in children with ASD.
Finally, anxiety levels may differ as a result of the differences 
in sample specificity. The study with lower prevalence rates of 
anxiety (30) included a large community sample of children 
with ASD, with anxiety levels that may not have reached clinical 
significance in all children. This study included a clinical Dutch 
sample with ASD children, who received treatment at a mental 
health institute because of the high daily impairment that in most 
cases was (partly) caused by the presence of high anxiety levels.
The higher parent ratings compared to the child ratings of 
anxiety could be explained by the family problems that were 
highly prevalent in this study. These problems could lead to 
less agreement between parents and children in their report of 
anxiety. Parents with conflicts, stress, or psychiatric symptoms 
may project their own problems on their children, leading to a 
parental overreport of anxiety symptoms (55). These discrepan­
cies suggest that it is important to use both child and parent 
report in studies on children with ASD.
The second aim was to investigate the risk factors for anxiety 
in this sample of children with ASD. More specifically, age, gen­
der, ASD subtype, and IQ were investigated as risk factors for 
anxiety in children with ASD. Parent­rated total anxiety symp­
toms were more prevalent among younger than among older 
children with ASD. This finding contradicts previous studies 
that have shown that anxiety increases with age in the ASD pop­
ulation [e.g., Ref. (18, 19)]. The findings in this study are more 
in line with research in the normal population showing that 
most anxiety disorders decrease with age, because childhood 
anxiety may lead to other psychopathology in adolescence, for 
example, depression (56). This similarity to the findings in the 
normal population may be due to the relatively high cognitive 
levels of the participating children compared to other studies 
in the ASD population (4), which may be related to a course 
of psychopathology levels over time that is also present in the 
normal population (18). When examining the findings on age 
differences in the prevalence of separation anxiety and specific 
phobia symptoms in children with ASD, it can be concluded 
that these findings are also in line with previous research in 
the normal population. This research indicated early childhood 
as a risk period for separation anxiety and specific phobia and 
showed a decrease in prevalence from early childhood to mid 
adolescence (57, 58).
Concerning the differential prevalence rates of anxiety for 
boys and girls with ASD, girls with ASD had more anxiety 
than boys with ASD. This finding was not in line with previ­
ous research showing that there are no gender differences in 
anxiety between boys and girls with ASD (17, 21, 22). However, 
the finding that girls with ASD are more anxious than boys 
with ASD is consistent with research on gender differences 
in anxiety in the normal population (59). Again, this may be 
explained by the relatively high cognitive levels of the ASD 
sample in this study compared to other studies (4), leading 
to the same neuropsychological basis of gender differences in 
anxiety as in the normal population (23). Moreover, the higher 
prevalence of anxiety in girls in this study could be explained 
by the higher acceptability of female anxiety by parents (60), 
which may have led to underreport of clinical anxiety in boys 
by parents. Moreover, having ASD is related to higher stress lev­
els (61), which in turn leads to a more profound expression of 
personality traits in terms of coping strategies. Anxiety­related 
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personality traits (e.g., neuroticism) are more prevalent among 
girls than among boys (60), which suggest that girls with ASD 
show more anxious behavior and coping strategies than boys 
with ASD.
The finding that ASD children with a higher PIQ and lower 
VIQ had more child­rated specific phobia symptoms is incon­
sistent with research showing that deficits in both receptive 
and expressive communication skills are related to less anxiety 
symptoms in children with ASD (28), but is consistent with 
the finding that children with PDD­NOS had higher anxi­
ety levels as communication deficits increased (29). There is 
some evidence that specific fears related to particular people, 
animals, or situations could be reduced by verbalization of feel­
ings (62), which may prevent the development of this kind of 
anxiety into a full specific phobia. ASD children with a higher 
PIQ and lower VIQ may have difficulty with verbalizing their 
feelings, explaining why they experience more symptoms of 
specific phobia. Other anxiety disorders may be more complex 
in nature, which may have led to a smaller, non­significant 
impact of these verbalization skills on the presence of these 
anxiety disorders.
On one hand, the finding that parent­rated anxiety is more 
prevalent in children with autistic disorder than in children 
with Asperger disorder and PDD­NOS contradicts some 
previous studies [e.g., Ref. (2, 9, 25)], but, on the other hand, 
this finding is more or less in line with other studies [e.g., Ref. 
(4, 19)]. A possible explanation for the inconsistent findings on 
ASD subtype as risk factor for anxiety is the limited validity in 
how ASD subtypes are assigned in the DSM­IV, with similar 
core symptom presentations across subtypes (63). This limited 
specificity of subtypes may have led to the variation in anxi­
ety levels in children with different ASD subtypes between the 
existing studies. The low validity of the ASD subtypes in the 
DSM­IV was the rationale for moving to a categorical system in 
the new DSM­V with a single diagnostic dimension: severity of 
ASD symptoms (38).
There are some limitations in this study. The intelligence 
levels of the participating children were not always known, 
leading to a considerably smaller number of children that 
could be included in this part of the analyses. Despite the esti­
mations of the missing values that were made in the analyses, 
these missing values could have lowered the reliability of the 
statistical results. Moreover, the questionnaires (SCAS­C/P) in 
this study were not specially designed for children with ASD 
(2). Also, it is possible that not only pure anxiety symptoms 
were measured with the SCAS, but also impairments that are 
related to the core ASD symptoms (e.g., social withdrawal as 
a consequence of high arousal). As a consequence, the partici­
pating children with ASD may not have accurately reported 
their anxiety symptoms. In their review on the use of anxiety 
assessment tools in children with ASD, Grondhuis and Aman 
(64) reported that the lack of psychometric characteristics for 
the ASD population of the SCAS may lead to an unreliable 
assessment of anxiety. However, they also state that the SCAS 
might be useful for ASD children who are higher functioning 
and who have moderate language and cognitive abilities (64), 
which are characteristics that are applicable to the participating 
children in the present study. Moreover, it is possible that not 
only the presence of an ASD was related to the high level of 
anxiety symptoms in this study but also other comorbid dis­
orders such as attention deficit hyperactivity disorder, which 
has also shown to be highly related to anxiety in children 
[e.g., Ref. (65)]. Finally, the lack of a comparison group and 
the use of norms could possibly have biased the outcomes in 
this study.
One clear message from this study is the high extent to 
which anxiety problems co­occur with ASD in a clinical sample 
of children. When children with ASD are referred to a mental 
health institute, they often have subclinical or clinical levels of 
anxiety. However, what we do not yet know is the developmen­
tal sequelae of these disorders and the impact each has on the 
other over time. Future research using longitudinal designs to 
investigate the mechanisms responsible for the development of 
anxiety in children with ASD seems warranted. Moreover, it is 
important to investigate the reliability and validity of the new 
ASD classifications in the DSM­V and the predictive validity 
of anxiety questionnaires in the population of children with 
ASD, because this may lead to less sample and methodological 
heterogeneity. These suggested future studies could eventu­
ally lead to a more extensive, more valid, and more reliable 
explanatory framework for the development of anxiety in 
children with ASD.
This study has some implications for clinical practice. The 
findings suggest that children with ASD have a high risk to 
have co­occurring anxiety symptoms. Especially girls and 
younger children with ASD may be at risk to develop anxiety. 
Therefore, early prevention of anxiety in children with ASD 
who are most at risk is important. On basis of the results of this 
study, it seems especially important to offer an anxiety pre­
vention program to young girls (e.g., in the age of 4–8 years) 
with ASD. Moreover, this study showed that a considerable 
number of children with ASD already met the criteria of one or 
more anxiety disorders. Currently, anxiety is often interpreted 
as a part of the ASD in clinical practice, which may lead to 
an underreporting and thus lack of treatment for anxiety 
as a separate condition (“diagnostic overshadowing” (66)). 
When anxiety in children with ASD is treated, this may also 
lead to a decrease in impairment caused by the core ASD 
symptoms (2). Thus, attention has to be paid to the assess­
ment of the presence of anxiety disorders when children with 
ASD are referred to or receive mental health care. When 
children with ASD meet the criteria for one or more anxi­
ety disorders, it is important that they receive treatment for 
their anxiety symptoms that is adapted to their capacities and 
difficulties.
eThics sTaTeMenT
The present study was carried out in accordance with the 
ethical standards of the medical ethics committee CMO Arnhem­
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